Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MARCUS CORP
Report date May 01, 2026 · Filed May 06, 2026
Section 16 reporting ended · disclosed 2026-05-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,044 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Tax withholding · Disposed 12,218 · Balance 37,044 F1: Shares withheld from the vesting of shares of restricted stock granted March 1, 2023, February 22, 2024, February 12, 2025, and February 11, 2026 to pay resulting tax amounts owed.to pay resulting tax amounts owed. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.20 · Expires 2027-02-28 | Direct | 3,500 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 3,500 F2: The options originally granted vest as follows: 40% after 2nd anniversary of the date of grant; 60% after 3rd anniversary; 80% after 4th anniversary; and 100% after 5 years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.00 · Expires 2028-02-27 | Direct | 3,500 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 3,500 F3: The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.90 · Expires 2029-02-26 | Direct | 3,500 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 3,500 F3: The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.88 · Expires 2030-02-25 | Direct | 3,500 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 3,500 F3: The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.71 · Expires 2030-05-08 | Direct | 1,750 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 1,750 F3: The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.84 · Expires 2031-03-09 | Direct | 4,200 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 4,200 F3: The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.04 · Expires 2032-03-08 | Direct | 3,500 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 3,500 F3: The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.99 · Expires 2033-05-07 | Direct | 27,500 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 27,500 F3: The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld from the vesting of shares of restricted stock granted March 1, 2023, February 22, 2024, February 12, 2025, and February 11, 2026 to pay resulting tax amounts owed.to pay resulting tax amounts owed.
F2: The options originally granted vest as follows: 40% after 2nd anniversary of the date of grant; 60% after 3rd anniversary; 80% after 4th anniversary; and 100% after 5 years.
F3: The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 6, 2026 22:40 UTC | MARCUS CORP MCS · Entity 5078 | Tax withholdingCommon Stock | 12,218 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-26-001054 · form4.xml · nonDerivative · entry 1 Gramz Mark A · CIK 0001987675 · Pres., Marcus Theatres 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,044 F1 · kind: Shares withheld from the vesting of shares of restricted stock granted March 1, 2023, February 22, 2024, February 12, 2025, and February 11, 2026 to pay resulting tax amounts owed.to pay resulting tax amounts owed. Read SEC document |
| February 22, 2026 Filed Feb 25, 2026 00:34 UTC | MARCUS CORP MCS · Entity 5078 | Tax withholdingCommon Stock | 2,899 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-26-000437 · form4.xml · nonDerivative · entry 1 Gramz Mark A · CIK 0001987675 · Pres., Marcus Theatres 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,262 F1 · kind: Shares withheld from the vesting of shares of restricted stock granted February 22, 2026 to pay resulting tax amounts owed.to pay resulting tax amounts owed. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:53 UTC | MARCUS CORP MCS · Entity 5078 | GrantCommon Stock | 16,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-26-000338 · form4.xml · nonDerivative · entry 1 Gramz Mark A · CIK 0001987675 · Pres., Marcus Theatres 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,161 F1 · kind: Restricted stock granted February 11, 2026 vests and becomes exercisable as follows: 50% after 2nd anniversary of date of grant and 100% after 3rd anniversary of date of grant. Read SEC document |
| May 15, 2025 Filed Jun 24, 2025 20:52 UTC | MARCUS CORP MCS · Entity 5078 | SaleCommon Stock | 5,138.8942 | $8.33 | $42,805.45 |
DisclosureSEC source: 0000897069-25-001135 · form4.xml · nonDerivative · entry 1 Gramz Mark A · CIK 0001987675 · Pres., Marcus Theatres Corp* 10b5-1 filing: No plan indicated Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 Read SEC document |
| February 12, 2025 Filed Feb 15, 2025 00:49 UTC | MARCUS CORP MCS · Entity 5078 | GrantCommon Stock | 11,390 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-25-000284 · form4.xml · nonDerivative · entry 1 Gramz Mark A · CIK 0001987675 · Pres., Marcus Theatres Corp* 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,761 F1 · shares: Restricted stock granted February 12, 2025 vests and becomes exercisable as follows: 50% after 2nd anniversary of date of grant and 100% after 3rd anniversary of date of grant. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:15 UTC | MARCUS CORP MCS · Entity 5078 | GrantCommon Stock | 16,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-24-000505 · form4.xml · nonDerivative · entry 1 Gramz Mark A · CIK 0001987675 · Pres., Marcus Theatres Corp* 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,371 F1 · shares: Restricted stock granted February 22, 2024 vests and becomes exercisable as follows: 50% after 2nd anniversary of date of grant and 100% after 3rd anniversary of date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.